Other GLP-1 and related medications Liraglutide (Saxenda, Victoza): Refrigerate before first use at 36 to 46 degrees Fahrenheit
(1999) Increased mortality associated with growth hormone treatment in critically ill adults
Source: #Healthcare #Pharma #GLP1 #Obesity #HealthPolicy #Innovation GLP-1 drugs for obesity: Cost-effective, but coverage uncertain As reported by Axios International Vitals, the leading GLP-1 drugs from Novo Nordisk and Eli Lilly and Company are now becoming cost-effective for treating obesity, according to a new analysis from the Institute for Clinical and Economic Review (ICER): Why does this matter
Age-related changes in renal function, hepatic metabolism, and tissue perfusion theoretically could influence peptide clearance and distribution, though no studies have systematically examined age effects
Insulin secretion from oral glucose intake is greater than insulin secretion from IV glucose, termed the incretin effect [13]